<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01969500</url>
  </required_header>
  <id_info>
    <org_study_id>MH100195-01</org_study_id>
    <nct_id>NCT01969500</nct_id>
  </id_info>
  <brief_title>Development of a Mobile System for Self-management of Schizophrenia (SOS)</brief_title>
  <official_title>Development of a Mobile System for Self-management of Schizophrenia (SOS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This 2-arm clinical trial piloted a mobile Self-Management of Schizophrenia (SOS) system that
      administers interventions targeting persistent symptoms of psychosis, social dysfunction, and
      medication adherence. Researchers compared an intervention arm using the SOS system and an
      arm receiving treatment as usual on the outcomes of change in severity of psychotic symptoms
      and change in social functioning.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Severity of Psychotic Symptoms</measure>
    <time_frame>Baseline, week 12</time_frame>
    <description>Severity of Psychotic Symptoms was assessed with the Psychotic Symptom Rating Scales (PSYRATS). The PSYRATS is comprised of 17 items inquiring about the specific dimensions of hallucinations and delusions, with each item being rated from 0 (absent) to 4 (severe). The PSYRATS has 2 subscales: the auditory hallucinations subscale (AHS) consisting of 11 items, and the delusions subscale (DS) consisting of 6 items. These subscale scores are added to create a total score ranging from 0-68. Higher scores indicate worse symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Social Functioning</measure>
    <time_frame>Baseline, week 12</time_frame>
    <description>Social Functioning was measured using two subscales from the Social Functioning Scale (SFS): Social Engagement (5-items) and Withdrawal &amp; Communication (10-items). The item values range from 0 (almost never) to 3 (often). The two subscales were summed to give a score between 0-45. A higher score indicates greater social functioning.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in System Use</measure>
    <time_frame>4 weeks</time_frame>
    <description>System use was measured by the SOS application regarding the percent of SOS prompts and self-report interactions with the system.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability and Satisfaction</measure>
    <time_frame>4 weeks</time_frame>
    <description>Usability and Satisfaction was measured using the USE (Usefulness, Satisfaction, and Ease of use) Questionnaire, which was designed to measure satisfaction, usefulness, ease of use and ease of learning.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Schizoaffective Disorder</condition>
  <arm_group>
    <arm_group_label>Treatment as Usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment as usual includes outpatient case management, linkage to services and medication monitoring.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mobile Application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mobile Application system designed to improve coping with psychotic symptoms, social functioning, and medication adherence.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mobile Application</intervention_name>
    <arm_group_label>Mobile Application</arm_group_label>
    <other_name>Self-Management of Schizophrenia (SOS)</other_name>
    <other_name>FOCUS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Treatment as Usual (TAU)</intervention_name>
    <arm_group_label>Treatment as Usual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DSM-IV (Diagnostic and Statistical Manual IV) criteria for schizophrenia or
             schizoaffective disorder based on a chart diagnosis;

          -  18 years or older;

          -  Prescribed oral antipsychotic medication; and

          -  A rating of &quot;3&quot; or lower on one of the three items which comprise the Domination by
             Symptoms factor from the Recovery Assessment Scale, indicating patient-rated need for
             illness self-management

        Exclusion Criteria:

          -  Hearing, vision, or motor impairment that make it impossible to operate a smartphone
             or respond to prompts (determined using demonstration smartphone for screening); and

          -  English reading level below 4th grade (determined using the Wide Range Achievement
             Test - 4th Edition)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dror Ben-Zeev, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Mental Health Center of Greater Manchester</name>
      <address>
        <city>Manchester</city>
        <state>New Hampshire</state>
        <zip>03103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>October 15, 2013</study_first_submitted>
  <study_first_submitted_qc>October 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2013</study_first_posted>
  <results_first_submitted>August 1, 2018</results_first_submitted>
  <results_first_submitted_qc>February 12, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 13, 2019</results_first_posted>
  <last_update_submitted>February 12, 2019</last_update_submitted>
  <last_update_submitted_qc>February 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Schizophrenia</keyword>
  <keyword>Schizoaffective Disorder</keyword>
  <keyword>Self Management of Schizophrenia</keyword>
  <keyword>SOS</keyword>
  <keyword>Serious Mental Illness</keyword>
  <keyword>Psychosis</keyword>
  <keyword>Social Dysfunction</keyword>
  <keyword>Medication Adherence</keyword>
  <keyword>Mobile Application</keyword>
  <keyword>EHealth</keyword>
  <keyword>E-Health</keyword>
  <keyword>Health Technology</keyword>
  <keyword>mobile health</keyword>
  <keyword>m-Health</keyword>
  <keyword>electronic health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 25, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/00/NCT01969500/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Individuals with schizophrenia or schizoaffective disorder who were receiving services were recruited through flyers in waiting rooms and bulletin boards at treatment centers, and through referrals from clinical staff. Enrollment was open from November 2015 to July 2016.</recruitment_details>
      <pre_assignment_details>N=3 enrolled participants were not assigned because N=1 did not pass a competency screener, N=1 did not meet Recovery Assessment Scale inclusion criteria, and N= 1 was no longer interested prior to completing baseline.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Treatment as Usual</title>
          <description>Treatment as usual includes outpatient case management, linkage to services and medication monitoring.
Treatment as Usual</description>
        </group>
        <group group_id="P2">
          <title>Mobile Application</title>
          <description>Mobile Application system designed to improve coping with psychotic symptoms, social functioning, and medication adherence.
Mobile Application</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>extended hospitalization</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment as Usual</title>
          <description>Treatment as usual includes outpatient case management, linkage to services and medication monitoring.
Treatment as Usual</description>
        </group>
        <group group_id="B2">
          <title>Mobile Application</title>
          <description>Mobile Application system designed to improve coping with psychotic symptoms, social functioning, and medication adherence.
Mobile Application</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="26"/>
            <count group_id="B3" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.0" spread="12.5"/>
                    <measurement group_id="B2" value="42.5" spread="13.4"/>
                    <measurement group_id="B3" value="42.7" spread="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Beliefs about Medicines Questionnaire - General (BMQ - General)</title>
          <description>The Beliefs about Medicine Questionnaire - General (BMQ - General) comprises two 4-item factors with 5-point Likert scales assessing beliefs that medicines are harmful, addictive, poisons which should not be taken continuously and that medicines are overused by doctors. Total scores range from 8-40. Higher scores indicate more negative beliefs about medicines.</description>
          <population>N=1 participant in the mobile application arm did not complete the baseline assessment and is not included in analysis for all measures except ISI.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.96" spread="4.57"/>
                    <measurement group_id="B2" value="20.32" spread="4.36"/>
                    <measurement group_id="B3" value="20.14" spread="4.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Beliefs about Medicines Questionnaire - Specific (BMQ - Specific)</title>
          <description>The Beliefs about Medicines Questionnaire - Specific (BMQ - Specific) comprises two 5-item factors with 5-point Likert scales assessing beliefs about the necessity of prescribed medication and concerns about prescribed medication based on beliefs about the danger of dependence, long-term toxicity, and the disruptive effects of medication. Total scores range from 10-50. Higher scores represent more negative beliefs about taking prescribed medication.</description>
          <population>N=1 participant in the mobile application arm did not complete the baseline assessment and is not included in analysis for all measures except ISI.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.56" spread="5.24"/>
                    <measurement group_id="B2" value="32.20" spread="4.49"/>
                    <measurement group_id="B3" value="32.38" spread="4.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Schizophrenia Patient Activation Measure (SPAM)</title>
          <description>The Schizophrenia Patient Activation Measure (SPAM) is an adaptation of the Patient Activation Measure (PAM). This measure is 14 items with 5-point Likert responses. It measures confidence in self-management and understanding of the participant's schizophrenia. Scores range from 14-70. Higher scores indicate more confidence in self-management and understanding of the participant's schizophrenia.</description>
          <population>N=1 participant in the mobile application arm did not complete the baseline assessment and is not included in analysis for all measures except ISI.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.28" spread="5.73"/>
                    <measurement group_id="B2" value="57.48" spread="5.25"/>
                    <measurement group_id="B3" value="56.88" spread="5.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Beck Depression Inventory (BDI)</title>
          <description>The Beck Depression Inventory (BDI) is a psychometric test for measuring the severity of depression with 21 questions on a 4-point scale. The scores range from 0-63. Higher scores indicate more severe depressive symptoms.</description>
          <population>N=1 participant in the mobile application arm did not complete the baseline assessment and is not included in analysis for all measures except ISI.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17.68" spread="10.85"/>
                    <measurement group_id="B2" value="14.12" spread="8.07"/>
                    <measurement group_id="B3" value="15.90" spread="9.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Insomnia Severity Index (ISI)</title>
          <description>Insomnia Severity Index (ISI) is a 7-item, 5-point Likert scale self-report instrument measuring the participant's perception of his or her insomnia. Scores range from 0 to 28. Higher scores indicate the participant perceives his or her insomnia as more severe.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.56" spread="7.17"/>
                    <measurement group_id="B2" value="6.73" spread="5.68"/>
                    <measurement group_id="B3" value="7.15" spread="6.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Working Alliance Inventory (WAI)</title>
          <description>The Working Alliance Inventory (WAI) is a 12-item scale with 7-point Likert responses that provides an overall measure of alliance between patients and clinical support workers. Scores can range from 12 to 84. Higher scores indicate a better alliance between the patient and the clinical support worker.</description>
          <population>N=1 participant in the mobile application arm did not complete the baseline assessment and is not included in analysis for all measures except ISI.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.68" spread="12.93"/>
                    <measurement group_id="B2" value="66.28" spread="11.43"/>
                    <measurement group_id="B3" value="65.48" spread="12.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Severity of Psychotic Symptoms</title>
        <description>Severity of Psychotic Symptoms was assessed with the Psychotic Symptom Rating Scales (PSYRATS). The PSYRATS is comprised of 17 items inquiring about the specific dimensions of hallucinations and delusions, with each item being rated from 0 (absent) to 4 (severe). The PSYRATS has 2 subscales: the auditory hallucinations subscale (AHS) consisting of 11 items, and the delusions subscale (DS) consisting of 6 items. These subscale scores are added to create a total score ranging from 0-68. Higher scores indicate worse symptoms.</description>
        <time_frame>Baseline, week 12</time_frame>
        <population>N=1 participant in the mobile application arm did not complete the baseline assessment and is not included in analysis for all measures except ISI.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment as Usual</title>
            <description>Treatment as usual includes outpatient case management, linkage to services and medication monitoring.
Treatment as Usual</description>
          </group>
          <group group_id="O2">
            <title>Mobile Application</title>
            <description>Mobile Application system designed to improve coping with psychotic symptoms, social functioning, and medication adherence.
Mobile Application</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Severity of Psychotic Symptoms</title>
          <description>Severity of Psychotic Symptoms was assessed with the Psychotic Symptom Rating Scales (PSYRATS). The PSYRATS is comprised of 17 items inquiring about the specific dimensions of hallucinations and delusions, with each item being rated from 0 (absent) to 4 (severe). The PSYRATS has 2 subscales: the auditory hallucinations subscale (AHS) consisting of 11 items, and the delusions subscale (DS) consisting of 6 items. These subscale scores are added to create a total score ranging from 0-68. Higher scores indicate worse symptoms.</description>
          <population>N=1 participant in the mobile application arm did not complete the baseline assessment and is not included in analysis for all measures except ISI.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.20" spread="3.20"/>
                    <measurement group_id="O2" value="19.88" spread="3.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.98" spread="3.24"/>
                    <measurement group_id="O2" value="20.96" spread="3.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.85</p_value>
            <method>Linear mixed effects model</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.71</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.81</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.37</ci_lower_limit>
            <ci_upper_limit>6.96</ci_upper_limit>
            <estimate_desc>Mean difference (Intervention Arm - TAU) in change from baseline to 12 weeks</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Social Functioning</title>
        <description>Social Functioning was measured using two subscales from the Social Functioning Scale (SFS): Social Engagement (5-items) and Withdrawal &amp; Communication (10-items). The item values range from 0 (almost never) to 3 (often). The two subscales were summed to give a score between 0-45. A higher score indicates greater social functioning.</description>
        <time_frame>Baseline, week 12</time_frame>
        <population>N=1 participant in the mobile application arm did not complete the baseline assessment and is not included in analysis for all measures except ISI.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment as Usual</title>
            <description>Treatment as usual includes outpatient case management, linkage to services and medication monitoring.
Treatment as Usual</description>
          </group>
          <group group_id="O2">
            <title>Mobile Application</title>
            <description>Mobile Application system designed to improve coping with psychotic symptoms, social functioning, and medication adherence.
Mobile Application</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Social Functioning</title>
          <description>Social Functioning was measured using two subscales from the Social Functioning Scale (SFS): Social Engagement (5-items) and Withdrawal &amp; Communication (10-items). The item values range from 0 (almost never) to 3 (often). The two subscales were summed to give a score between 0-45. A higher score indicates greater social functioning.</description>
          <population>N=1 participant in the mobile application arm did not complete the baseline assessment and is not included in analysis for all measures except ISI.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.60" spread="1.15"/>
                    <measurement group_id="O2" value="25.96" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.28" spread="1.17"/>
                    <measurement group_id="O2" value="26.34" spread="1.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.44</p_value>
            <method>Linear mixed effects model</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.30</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.67</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.66</ci_lower_limit>
            <ci_upper_limit>2.06</ci_upper_limit>
            <estimate_desc>Mean difference (Intervention Arm - TAU) in change from baseline to 12 weeks</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in System Use</title>
        <description>System use was measured by the SOS application regarding the percent of SOS prompts and self-report interactions with the system.</description>
        <time_frame>4 weeks</time_frame>
        <population>This data was collected in a previous field trial, not in this randomized controlled trial.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment as Usual</title>
            <description>Treatment as usual includes outpatient case management, linkage to services and medication monitoring.
Treatment as Usual</description>
          </group>
          <group group_id="O2">
            <title>Mobile Application</title>
            <description>Mobile Application system designed to improve coping with psychotic symptoms, social functioning, and medication adherence.
Mobile Application</description>
          </group>
        </group_list>
        <measure>
          <title>Change in System Use</title>
          <description>System use was measured by the SOS application regarding the percent of SOS prompts and self-report interactions with the system.</description>
          <population>This data was collected in a previous field trial, not in this randomized controlled trial.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Usability and Satisfaction</title>
        <description>Usability and Satisfaction was measured using the USE (Usefulness, Satisfaction, and Ease of use) Questionnaire, which was designed to measure satisfaction, usefulness, ease of use and ease of learning.</description>
        <time_frame>4 weeks</time_frame>
        <population>This data was collected in a previous field trial, not in this randomized controlled trial.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment as Usual</title>
            <description>Treatment as usual includes outpatient case management, linkage to services and medication monitoring.
Treatment as Usual</description>
          </group>
          <group group_id="O2">
            <title>Mobile Application</title>
            <description>Mobile Application system designed to improve coping with psychotic symptoms, social functioning, and medication adherence.
Mobile Application</description>
          </group>
        </group_list>
        <measure>
          <title>Usability and Satisfaction</title>
          <description>Usability and Satisfaction was measured using the USE (Usefulness, Satisfaction, and Ease of use) Questionnaire, which was designed to measure satisfaction, usefulness, ease of use and ease of learning.</description>
          <population>This data was collected in a previous field trial, not in this randomized controlled trial.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Assessed at the baseline and 12 week assessments for each participant.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Treatment as Usual</title>
          <description>Treatment as usual includes outpatient case management, linkage to services and medication monitoring.
Treatment as Usual</description>
        </group>
        <group group_id="E2">
          <title>Mobile Application</title>
          <description>Mobile Application system designed to improve coping with psychotic symptoms, social functioning, and medication adherence.
Mobile Application</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dror Ben-Zeev</name_or_title>
      <organization>University of Washington</organization>
      <phone>(206) 685-9655</phone>
      <email>dbenzeev@uw.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

